CYTK vs PTC · rev $28.6M vs P/E 48, rev $2.74B
Cytokinetics Inc (CYTK) versus PTC Inc (PTC) — a side-by-side from cached financials, not a winner call.
Cytokinetics Inc (CYTK) is a biotechnology company listed on US.
PTC Inc (PTC) is a software - application company listed on US.
Latest reported CYTK revenue for 2026-06-30 was $28.6M. Net income was -$198.8M. Revenue was up 47.9% from 2026-03-31 to 2026-06-30. CYTK currently screens at market cap $4.05B.
Latest reported PTC revenue for 2025-09-30 was $2.74B. Net income was $734.0M. PTC currently screens at market cap $21.11B and trailing P/E 48.3.
CYTK currently screens at market cap $4.05B. PTC currently screens at market cap $21.11B and trailing P/E 48.3.
Not investment advice. Open the CYTK and PTC stock pages for the full models.
Not investment advice.